Smoking and aggressive prostate cancer: A review of the epidemiologic evidence

Cancer Causes and Control

Volumn 20, Issue 10, 2009, Pages 1799-1810

  Zu, Ke ^a   Giovannucci, Edward ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Aggressive prostate cancer; Epidemiology; Smoking

Indexed keywords

ALPHA TOCOPHEROL; ANDROSTANOLONE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; MULTIDRUG RESISTANCE PROTEIN 1; TESTOSTERONE;

BRACHYTHERAPY; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RESEARCH; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPOSURE; FATALITY; FOLLOW UP; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; REVIEW; RISK ASSESSMENT; RISK FACTOR; TUMOR DIFFERENTIATION;

DISEASE PROGRESSION; HUMANS; INCIDENCE; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; RISK FACTORS; SMOKING; SURVIVAL ANALYSIS;

EID: 71349086684     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9387-y     Document Type: Review

References (57)

1. A Jemal R Siegel E Ward, et al.. 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 10.3322/CA.2007.0010 18287387
2. V Assikis OW Brawley 2004 Chemoprevention in prostate cancer Curr Probl Cancer 28 218 230 10.1016/j.currproblcancer.2004.05.002 15318324 (Pubitemid 39070352)
3. GL Andriole ED Crawford RL Grubb III, et al.. 2009 Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 1310 1319 10.1056/NEJMoa0810696 1:CAS:528:DC%2BD1MXjs1ejsLk%3D 19297565
4. FH Schroder J Hugosson MJ Roobol, et al.. 2009 Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 1320 1328 10.1056/NEJMoa0810084 19297566
5. K Hickey KA Do A Green 2001 Smoking and prostate cancer Epidemiol Rev 23 115 125 1:STN:280:DC%2BD3Mrkt1SlsQ%3D%3D 11588835
6. F Levi C La Vecchia 2001 Tobacco smoking and prostate cancer: time for an appraisal Ann Oncol 12 733 738 10.1023/A:1011124523984 1:STN:280: DC%2BD38%2FislSksQ%3D%3D 11484946 (Pubitemid 32655080)
7. E Giovannucci Y Liu EA Platz MJ Stampfer WC Willett 2007 Risk factors for prostate cancer incidence and progression in the health professionals follow-up study Int J Cancer 121 1571 1578 10.1002/ijc.22788 1:CAS:528:DC%2BD2sXhtVSns7zO 17450530 (Pubitemid 47328718)
8. JM Carstensen G Pershagen G Eklund 1987 Mortality in relation to cigarette and pipe smoking: 16 years' observation of 25, 000 Swedish men J Epidemiol Community Health 41 166 172 10.1136/jech.41.2.166 1:STN:280: DyaL1c%2FgvFKlsQ%3D%3D 3655638
9. S Akiba T Hirayama 1990 Cigarette smoking and cancer mortality risk in Japanese men and women-results from reanalysis of the six-prefecture cohort study data Environ Health Perspect 87 19 26 10.2307/3431001 1:STN:280: DyaK3M%2FpvFagsA%3D%3D 2269225
10. AW Hsing JK McLaughlin LM Schuman, et al.. 1990 Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study Cancer Res 50 6836 6840 1:STN:280:DyaK3M%2FgsVSnuw%3D%3D 2208150
11. AW Hsing JK McLaughlin Z Hrubec WJ Blot JF Fraumeni Jr 1991 Tobacco use and prostate cancer: 26-year follow-up of US veterans Am J Epidemiol 133 437 441 1:STN:280:DyaK3M7lslyluw%3D%3D 2000853
12. A Tverdal D Thelle I Stensvold P Leren K Bjartveit 1993 Mortality in relation to smoking history: 13 years' follow-up of 68, 000 Norwegian men and women 35-49 years J Clin Epidemiol 46 475 487 10.1016/0895-4356(93)90025-V 1:STN:280:DyaK3s3nsVejug%3D%3D 8501474 (Pubitemid 23194270)
13. R Doll R Peto K Wheatley R Gray I Sutherland 1994 Mortality in relation to smoking: 40 years' observations on male British doctors BMJ 309 901 911 1:STN:280:DyaK2M%2FjvVSltQ%3D%3D 7755693
14. HO Adami R Bergstrom G Engholm, et al.. 1996 A prospective study of smoking and risk of prostate cancer Int J Cancer 67 764 768 10.1002/(SICI)1097- 0215(19960917)67:6<764::AID-IJC3>3.0.CO;2-P 1:STN:280:DyaK28vitF2huw%3D%3D 8824546 (Pubitemid 26348803)
15. SS Coughlin JD Neaton A Sengupta 1996 Cigarette smoking as a predictor of death from prostate cancer in 348, 874 men screened for the multiple risk factor intervention trial Am J Epidemiol 143 1002 1006 1:STN:280: DyaK283ht1Oluw%3D%3D 8629606
16. C Rodriguez LM Tatham MJ Thun EE Calle CW Heath Jr 1997 Smoking and fatal prostate cancer in a large cohort of adult men Am J Epidemiol 145 466 475 1:STN:280:DyaK2s3gtVKqsA%3D%3D 9048521 (Pubitemid 27084219)
17. E Giovannucci EB Rimm A Ascherio, et al.. 1999 Smoking and risk of total and fatal prostate cancer in United States health professionals Cancer Epidemiol Biomark Prev 8 277 282 1:STN:280:DyaK1M3isVSgtw%3D%3D
18. PA Lotufo IM Lee UA Ajani CH Hennekens JE Manson 2000 Cigarette smoking and risk of prostate cancer in the physicians' health study (United States) Int J Cancer 87 141 144 10.1002/1097-0215(20000701)87:1<141::AID-IJC21>3.0. CO;2-A 1:STN:280:DC%2BD3czitFCnsw%3D%3D 10861465 (Pubitemid 30368428)
19. S Rohrmann JM Genkinger A Burke, et al.. 2007 Smoking and risk of fatal prostate cancer in a prospective U.S. study Urology 69 721 725 10.1016/j.urology.2006.12.020 17445658 (Pubitemid 46574914)
20. GD Batty M Kivimaki L Gray GD Smith MG Marmot MJ Shipley 2008 Cigarette smoking and site-specific cancer mortality: testing uncertain associations using extended follow-up of the original Whitehall study Ann Oncol 19 996 1002 10.1093/annonc/mdm578 1:STN:280:DC%2BD1c3nvFWnsw%3D%3D 18212091 (Pubitemid 351627320)
21. HW Daniell 1995 A worse prognosis for smokers with prostate cancer J Urol 154 153 157 10.1016/S0022-5347(01)67253-7 1:STN:280:DyaK2M3psFSntw%3D%3D 7776411
22. GP Yu JS Ostroff ZF Zhang J Tang SP Schantz 1997 Smoking history and cancer patient survival: a hospital cancer registry study Cancer Detect Prev 21 497 509 1:STN:280:DyaK1c%2FmtFensg%3D%3D 9398990
23. MG Oefelein MI Resnick 2004 Association of tobacco use with hormone refractory disease and survival of patients with prostate cancer J Urol 171 2281 2284 10.1097/01.ju.0000125123.46733.93 15126803 (Pubitemid 38625452)
24. T Pickles M Liu E Berthelet C Kim-Sing W Kwan S Tyldesley 2004 The effect of smoking on outcome following external radiation for localized prostate cancer J Urol 171 1543 1546 10.1097/01.ju.0000118292.25214.a4 1:STN:280:DC%2BD2c7js1yluw%3D%3D 15017216 (Pubitemid 38365414)
25. J Pantarotto S Malone S Dahrouge V Gallant L Eapen 2007 Smoking is associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy BJU Int 99 564 569 10.1111/j.1464-410X.2006.06656.x 17166241 (Pubitemid 46238829)
26. Z Gong I Agalliu DW Lin JL Stanford AR Kristal 2008 Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men Cancer Causes Control 19 25 31 10.1007/s10552-007-9066-9 17906959
27. R Doll R Peto J Boreham I Sutherland 2005 Mortality from cancer in relation to smoking: 50 years observations on British doctors Br J Cancer 92 426 429 10.1038/sj.bjc.6602450 1:STN:280:DC%2BD2M%2Fnt1WisA%3D%3D 15668706 (Pubitemid 40604414)
28. F Hussain H Aziz R Macchia M Avitable M Rotman 1992 High grade adenocarcinoma of prostate in smokers of ethnic minority groups and Caribbean Island immigrants Int J Radiat Oncol Biol Phys 24 451 461 1:STN:280: DyaK3s%2FhsFWhtA%3D%3D 1399730
29. JR Cerhan JC Torner CF Lynch, et al.. 1997 Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States) Cancer Causes Control 8 229 238 10.1023/A:1018428531619 1:STN:280:DyaK2s3nvFyksQ%3D%3D 9134247 (Pubitemid 27170378)
30. MR Spitz SS Strom Y Yamamura, et al.. 2000 Epidemiologic determinants of clinically relevant prostate cancer Int J Cancer 89 259 264 10.1002/1097- 0215(20000520)89:3<259::AID-IJC8>3.0.CO;2-F 1:STN:280: DC%2BD3czitFCisQ%3D%3D 10861502 (Pubitemid 30430742)
31. NL Kobrinsky MG Klug PJ Hokanson DE Sjolander L Burd 2003 Impact of smoking on cancer stage at diagnosis J Clin Oncol 21 907 913 10.1200/JCO.2003.05.110 12610192 (Pubitemid 46606451)
32. LA Plaskon DF Penson TL Vaughan JL Stanford 2003 Cigarette smoking and risk of prostate cancer in middle-aged men Cancer Epidemiol Biomark Prev 12 604 609 1:CAS:528:DC%2BD3sXlsVymsb0%3D
33. WW Roberts EA Platz PC Walsh 2003 Association of cigarette smoking with extraprostatic prostate cancer in young men J Urol 169 512 516 10.1016/S0022-5347(05)63945-6 12544299 (Pubitemid 36132974)
34. GS Merrick WM Butler KE Wallner RW Galbreath JH Lief E Adamovich 2004 Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 58 1056 1062 1:CAS:528: DC%2BD2cXhslWmtbc%3D 15001245
35. JM Zmuda JA Cauley A Kriska NW Glynn JP Gutai LH Kuller 1997 Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former multiple risk factor intervention trial participants Am J Epidemiol 146 609 617 1:STN:280: DyaK1c%2FgsVyksQ%3D%3D 9345114
36. WS Dai JP Gutai LH Kuller JA Cauley 1988 Cigarette smoking and serum sex hormones in men Am J Epidemiol 128 796 805 1:STN:280:DyaL1czjvVKjsg%3D%3D 3421245
37. MP Waalkes S Rehm 1994 Cadmium and prostate cancer J Toxicol Environ Health 43 251 269 10.1080/15287399409531920 1:CAS:528:DyaK2MXitV2lt70%3D 7966437
38. PM Pour 1983 Prostatic cancer induced in MRC rats by N-nitrosobis(2- oxopropyl)-amine and N-nitrosobis(2-hydroxypropyl)amine Carcinogenesis 4 49 55 10.1093/carcin/4.1.49 1:CAS:528:DyaL3sXht1Wjur8%3D 6185248
39. C Heeschen JJ Jang M Weis, et al.. 2001 Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis Nat Med 7 833 839 10.1038/89961 1:CAS:528:DC%2BD3MXltVagt70%3D 11433349 (Pubitemid 32691639)
40. RK Jain 2001 Clearing the smoke on nicotine and angiogenesis Nat Med 7 775 777 10.1038/89889 1:CAS:528:DC%2BD3MXltVSgsrg%3D 11433337 (Pubitemid 32691628)
41. AC Villablanca 1998 Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro J Appl Physiol 84 2089 2098 1:CAS:528:DyaK1cXktVSqsLo%3D 9609804
42. RG Hahn 2001 Smoking increases the risk of large scale fluid absorption during transurethral prostatic resection J Urol 166 162 165 10.1016/S0022- 5347(05)66100-9 1:STN:280:DC%2BD3MznslCmug%3D%3D 11435847
43. H Enokida H Shiina S Urakami, et al.. 2006 Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma Cancer 106 79 86 10.1002/cncr.21577 1:CAS:528:DC%2BD28XptF2rtA%3D%3D 16323173 (Pubitemid 43032551)
44. J Yang LX Qian HF Wu, et al.. 2006 Genetic polymorphisms in the cytochrome P450 1A1 and 2E1 genes, smoking, drinking and prostate cancer susceptibility: a case-control study in a Han nationality population in Southern China Int J Urol 13 773 780 10.1111/j.1442-2042.2006.01401.x 1:CAS:528:DC%2BD28XotFartL0%3D 16834659 (Pubitemid 43926771)
45. GE Mao G Morris QY Lu, et al.. 2004 Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer Cancer Detect Prev 28 368 374 10.1016/j.cdp.2004.07.003 1:CAS:528:DC%2BD2MXhs1egug%3D%3D 15542263 (Pubitemid 39471284)
46. LA Quinones CE Irarrazabal CR Rojas, et al.. 2006 Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study Asian J Androl 8 349 355 10.1111/j.1745-7262.2006.00135.x 1:CAS:528:DC%2BD28XltlKntr0%3D 16625286
47. T Hamasaki H Inatomi T Katoh, et al.. 2003 N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men Int J Urol 10 167 173 10.1046/j.1442-2042.2003.00586.x 1:CAS:528:DC%2BD3sXjsl2rsL4%3D 12622714 (Pubitemid 36470028)
48. M Wadelius JL Autrup MJ Stubbins, et al.. 1999 Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer Pharmacogenetics 9 333 340 10.1097/00008571-199906000-00008 1:CAS:528: DyaK1MXlsFGls78%3D 10471065
49. NL Nock X Liu MS Cicek, et al.. 2006 Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk Cancer Epidemiol Biomark Prev 15 756 761 10.1158/1055-9965.EPI-05-0826 1:CAS:528:DC%2BD28XjsVWrtLg%3D
50. SN Kelada SL Kardia AH Walker AJ Wein SB Malkowicz TR Rebbeck 2000 The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking Cancer Epidemiol Biomark Prev 9 1329 1334 1:CAS:528:DC%2BD3MXktFaitw%3D%3D
51. JA Agundez 2004 Cytochrome P450 gene polymorphism and cancer Curr Drug Metab 5 211 224 10.2174/1389200043335621 1:CAS:528:DC%2BD2cXktlKksrk%3D 15180491 (Pubitemid 38735776)
52. Anonymous (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 330:1029-1035
53. OP Heinonen D Albanes J Virtamo, et al.. 1998 Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial J Natl Cancer Inst 90 440 446 10.1093/jnci/90.6.440 1:CAS:528:DyaK1cXitlejtbs%3D 9521168
54. VA Kirsh RB Hayes ST Mayne, et al.. 2006 Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk J Natl Cancer Inst 98 245 254 1:CAS:528:DC%2BD28Xhs1SktrY%3D 16478743
55. AR Johnson A Munoz JL Gottlieb DF Jarrard 2007 High dose zinc increases hospital admissions due to genitourinary complications J Urol 177 639 643 10.1016/j.juro.2006.09.047 1:CAS:528:DC%2BD2sXhs1Wlsrw%3D 17222649 (Pubitemid 46054024)
56. JM Chan MJ Stampfer J Ma EB Rimm WC Willett EL Giovannucci 1999 Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States Cancer Epidemiol Biomark Prev 8 893 899 1:CAS:528:DyaK1MXns1CrtLg%3D
57. SM Lippman EA Klein PJ Goodman, et al.. 2009 Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT) JAMA 301 39 51 10.1001/jama.2008.864 1:CAS:528:DC%2BD1MXntFKmsw%3D%3D 19066370